Table 2 Categories and numbers of patients genotyped in AIDS GWAS meta-analysis
From: GWATCH: a web platform for automated gene association discovery analysis
Abbreviations | Risk groups | Number of patients for each group | Total | ||
|---|---|---|---|---|---|
Group A | Group B | Group C | B + C | ||
EA*-I | EA*-Total | AA** | |||
HREU | High Risk Exposed HIV Uninfected | 254 | 300 | 148 | 448 |
EU (except HREU) | Exposed HIV Uninfected (all risks) | 1 | 351 | 267 | 618 |
SC | Sero-Convertor | 703 | 767 | 288 | 1 055 |
SP-LTS | Sero-Prevalent-Long-Term-Survivor (no AIDS for >10 years) | 444 | 831 | 170 | 1 001 |
Sequelae | AIDS sequelae diagnosis | 461 | 1 848 | 0 | 1 848 |
HAART | Anti-retroviral treatment | 485 | 1 319 | 65 | 1 384 |
Total study participants | 1 527 | 4 462 | 1 460 | 5 922 | |